To require reporting regarding certain drug price increases, and for other purposes.
Summary
What This Bill Does
The bill provides reporting on justification for drug price increases Title III of the Public Health Service Act (42 U.S.C, provides 399OO. Reporting on justification for drug price increases, and provides 399OO–1. Use of civil penalty amounts. It relies on compliance mandates, appropriations, reporting requirements, and definition changes. The main policy areas are Healthcare Consumers, Healthcare, Environment, and Housing.
Who Benefits and How
Patients and health care consumers affected by the bill could face lower compliance burdens, Researchers and scientific institutions affected by the bill could face lower compliance burdens, and Homeowners, tenants, or housing market participants affected by the bill could face lower compliance burdens.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Homeowners, tenants, or housing market participants affected by the bill would take on compliance duties.
Key Provisions
- Provides reporting on justification for drug price increases Title III of the Public Health Service Act (42 U.S.C.
- Provides 399OO. Reporting on justification for drug price increases.
- Provides 399OO–1. Use of civil penalty amounts.
- Requires 399OO–2. Annual report to Congress Subject to subsection (b), the Secretary shall submit to Congress, and post on the public website of the Department of Health and Human Services in a way that is easy to find...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill provides reporting on justification for drug price increases Title III of the Public Health Service Act (42 U.S.C, provides 399OO. Reporting on justification for drug price increases, and provides 399OO–1. Use of civil penalty amounts.
Key Policy Areas
Healthcare Consumers, Healthcare, Environment, Housing
Primary Purpose
The bill provides reporting on justification for drug price increases Title III of the Public Health Service Act (42 U.S.C, provides 399OO. Reporting on justification for drug price increases, and provides 399OO–1. Use of civil penalty amounts.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Researchers and scientific institutions affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Environmental and public health interests affected by the bill
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Environmental and public health interests affected by the bill
Sponsors
Legislative Progress
IntroducedMs. Baldwin (for herself, Mr. Braun, and Ms. Smith) introduced …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology